Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatiosis in patients with non-alcoholic fatty liver disease

被引:562
作者
Araya, J
Rodrigo, R
Videla, LA
Thielemann, L
Orellana, M
Pettinelli, P
Poniachik, J
机构
[1] Univ Chile, Programa Farmacol Mol & Clin, Inst Ciencias Biomed, Fac Med, Santiago 7, Chile
[2] Univ Chile, Dept Nutr, Inst Ciencias Biomed, Fac Med, Santiago 7, Chile
[3] Univ Chile, Program Fisiopatol, Inst Ciencias Biomed, Fac Med, Santiago 7, Chile
[4] Univ Chile, Hosp Clin, Gastroenterol Serv, Santiago 7, Chile
关键词
lipid peroxidation; long-chain polyunsaturated fatty acid; obesity; oxidative stress; protein carbonylation; steatosis; trans fatty acid;
D O I
10.1042/CS20030326
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hepatic steatosis is a major feature associated with NAFLD (non-alcoholic fatty liver disease). The aims of the present study were to assess the levels of PUFA (polyunsaturated fatty acids) in liver total lipids, triacylglycerols (triglycerides) and phospholipids of NAFLD patients in relation to those in adipose tissue and hepatic indexes related to oxidative stress as factors contributing to hepatic steatosis. Eleven control subjects and 19 patients with NAFLD were studied. Analysis of liver and abdominal adipose tissue fatty acids was carried out by GLC. The liver content of protein carbonyl groups and malondialdehyde were taken as indexes related to oxidative stress. NAFLD patients had a depletion in LCPUFA (long-chain PUFA) of the n - 6 and n - 3 series in liver triacylglycerols, with decreased 20:4,n - 6/18:2,n - 6 and (20:5,n - 3 + 22:6,n - 3)/18:3,n - 3 ratios, whereas liver phospholipids contained higher n - 6 and lower n - 3 LCPUFA. These findings were accompanied by an enhancement of (i) n - 6/n - 3 ratio in liver and adipose tissue, (ii) 18:1,n - 9 trans levels in adipose tissue, and (iii) hepatic lipid peroxidation and protein oxidation indexes. It is concluded that a marked enhancement in LCPUFA n - 6/n - 3 ratio occurs in the liver of NAFLD patients, a condition that may favour lipid synthesis over oxidation and secretion, thereby leading to steatosis. Depletion of hepatic LCPUFA may result from both defective desaturation of PUFA, due to inadequate intake of precursors, such as 18:3,n - 3, and higher intake of the 18:1,n - 9 trans isomer leading to desaturase inhibition, and from an increased peroxidation of LCPUFA due to oxidative stress.
引用
收藏
页码:635 / 643
页数:9
相关论文
共 48 条
[1]   Red wine raises plasma HDL and preserves long-chain polyunsaturated fatty acids in rat kidney and erythrocytes [J].
Araya, J ;
Rodrigo, R ;
Orellana, M ;
Rivera, G .
BRITISH JOURNAL OF NUTRITION, 2001, 86 (02) :189-195
[2]   NONALCOHOLIC STEATOHEPATITIS - AN EXPANDED CLINICAL ENTITY [J].
BACON, BR ;
FARAHVASH, MJ ;
JANNEY, CG ;
NEUSCHWANDERTETRI, BA .
GASTROENTEROLOGY, 1994, 107 (04) :1103-1109
[3]   Adipose tissue biomarkers of fatty acid intake [J].
Baylin, A ;
Kabagambe, EK ;
Siles, X ;
Campos, H .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 76 (04) :750-757
[4]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[5]   The influence of different fats and fatty acids on obesity, insulin resistance and inflammation [J].
Bray, GA ;
Lovejoy, JC ;
Smith, SR ;
DeLany, JP ;
Lefevre, M ;
Hwang, D ;
Ryan, DH ;
York, DA .
JOURNAL OF NUTRITION, 2002, 132 (09) :2488-2491
[6]   Eicosapentaenoic and docosapentaenoic acids are the principal products of α-linolenic acid metabolism in young men [J].
Burdge, GC ;
Jones, AE ;
Wootton, SA .
BRITISH JOURNAL OF NUTRITION, 2002, 88 (04) :355-363
[7]   Conditionally essential fatty acid deficiencies in end-stage liver disease [J].
Burke, PA ;
Ling, PR ;
Forse, RA ;
Bistrian, BR .
NUTRITION, 1999, 15 (04) :302-304
[8]   Effects of fatty acids and growth hormone on liver fatty acid binding protein and PPARα in rat liver [J].
Carlsson, L ;
Lindén, D ;
Jalouli, M ;
Oscarsson, J .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 281 (04) :E772-E781
[9]   Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia [J].
Chan, DC ;
Watts, GF ;
Barrett, PHR ;
Beilin, LJ ;
Redgrave, TG ;
Mori, TA .
DIABETES, 2002, 51 (08) :2377-2386
[10]  
Clarke SD, 1999, AM J CLIN NUTR, V70, P566